Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.34 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL186678 | 0.98 | USP2 (0.50) | USP2APPHTTPLA2G2CLPAR5 | |
| SCHEMBL7461538 | 0.94 | USP2 (0.55) | USP2APPHTTPLA2G2CLPAR5 | |
| SCHEMBL3059380 | 0.88 | USP2 (0.46) | USP2KDM4EDUSP3MEN1KMT2A | |
| SCHEMBL1356119 | 0.86 | USP2 (0.44) | USP2LMNACYP1A2CYP2C19 | |
| SCHEMBL28396143 | 0.85 | USP2 (0.39) | USP2APPKDM4EDUSP3MEN1 | |
| SCHEMBL18507824 | 0.85 | APP (0.35) | USP2APPHTTLPAR5CYP1A2 | |
| SCHEMBL16265140 | 0.83 | USP2 (0.42) | USP2APPHTTPLA2G2CLPAR5 | |
| SCHEMBL186677 | 0.81 | USP2 (0.49) | USP2HTTPLA2G2CLPAR5KDM4E | |
| SCHEMBL29766363 | 0.81 | USP2 (0.37) | USP2APPKDM4EDUSP3MEN1 | |
| SCHEMBL29152290 | 0.80 | CYP3A4 (0.44) | USP2APPHTTPLA2G2CLPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7790665-B2 | Highly concentrated, aqueous oligoester and polyester formulations | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2010-09-07 | — | — | US | claimed |
| EP-2118192-B1 | AQUEOUS OLIGO- AND POLYESTER FORMULATIONS | CLARIANT FINANCE BVI LTD (VG) | 2010-05-26 | — | — | EP | claimed |
| US-20100098655-A1 | Aqueous Oligo- And Polyester Formulations | CLARIANT FINANCE (BVI) LIMITED (VG) | 2010-04-22 | — | — | US | claimed |
| US-20080139442-A1 | Highly Concentrated, Aqueous Oligoester And Polyester Formulations | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2008-06-12 | — | — | US | claimed |
| EP-1763559-B1 | HIGHLY CONCENTRATED, AQUEOUS OLIGOESTER AND POLYESTER FORMULATIONS | CLARIANT PRODUKTE DEUTSCHLAND (DE) | 2007-11-21 | — | — | EP | claimed |
| US-20040197293-A1 | Anionic polyurethanes with elastic property | L'OREAL S.A. (FR) | 2004-10-07 | — | — | US | claimed |
| JP-10203937-A | — | — | None | — | — | JP | disclosed |
| EP-4749015-A1 | ARTIFICIAL LEATHER, METHOD FOR PRODUCING SAME, AND USE OF SAME | Toray Industries, Inc. (JP) | 2026-05-27 | — | — | EP | disclosed |
| US-12584270-B2 | Artificial leather and method for manufacturing same | TORAY INDUSTRIES, INC. (JP) | 2026-03-24 | — | — | US | disclosed |
| EP-4613930-A1 | ARTIFICIAL LEATHER AND METHOD FOR MANUFACTURING SAME | Toray Industries, Inc. (JP) | 2025-09-10 | — | — | EP | disclosed |
| US-20250263571-A1 | Ink Jet Recording Method And Recording Apparatus | SEIKO EPSON CORPORATION (JP) | 2025-08-21 | — | — | US | disclosed |
| EP-4079961-B1 | SHEET MATERIAL AND METHOD FOR PRODUCING SAME | TORAY INDUSTRIES (JP) | 2025-07-09 | — | — | EP | disclosed |
| US-12338575-B2 | Sheet material and method for producing same | TORAY INDUSTRIES, INC. (JP) | 2025-06-24 | — | — | US | disclosed |
| WO-2006029746-A1 | WASHING, CARE, AND CONDITIONING AGENTS FOR TEXTILE MATERIAL | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2006-03-23 | — | — | WO | disclosed |
| WO-2005123835-A1 | HIGHLY CONCENTRATED, AQUEOUS OLIGOESTER AND POLYESTER FORMULATIONS | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2005-12-29 | — | — | WO | disclosed |
| EP-1600464-A1 | AQUEOUS POLYURETHANE RESIN DISPERSION AND SHEET MATERIAL OBTAINED FROM THE SAME | Sanyo Chemical Industries, Ltd. (JP) | 2005-11-30 | — | — | EP | disclosed |
| US-20050131081-A1 | Aqueous synthethic resin dispersion | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2005-06-16 | — | — | US | disclosed |
| US-20040197293-A1 | Anionic polyurethanes with elastic property | L'OREAL S.A. (FR) | 2004-10-07 | — | — | US | disclosed |
| US-20040062989-A1 | Binding agent for electrode of electrochemical element and electrode | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2004-04-01 | — | — | US | disclosed |
| JP-H10203937-A | TREATING AGENT FOR HAIR | SANYO CHEM IND LTD | 1998-08-04 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584270-B2 | Artificial leather and method for manufacturing same | LANCL2, TLL2, H1-0 | USP2 138/4885APP 2378/4885HTT 3914/4885 |
| US-20100098655-A1 | Aqueous Oligo- And Polyester Formulations | PHOSPHO1, PPA1, PGLS | USP2 1870/4885APP 3727/4885HTT 2815/4885 |
| US-20040197293-A1 | Anionic polyurethanes with elastic property | PUF60, PHOSPHO1, PLA2G2C | USP2 1779/4885APP 4291/4885HTT 463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.